Method
General
Results
Vocab
Wild
100

How many total patients were included in this study?

1167

100

What weeks were patients assessed at?

0 weeks (baseline)
4 w
8 w
12 w
24 w

100

Outcomes were measured at week ______.

8

100

What are clinical considerations?

The states rationale for a medication's classification and offer treatment adjustments if a clinician desires to use the selected medication.

100

How is this study blinded, since the doctor had to know whether they were using the GeneSight test or not?

Blinded for two groups- patients and raters. All patients received the buccal swab.

200

How many study sites were included?

60
-20 academic
-40 community

200

What were the patient requirements to be included in the study? (3)

-over 18
-diagnosed with MDD
-failed at least one psychotropic medication in the current depressive episode
*excluded if suicidal, co-occuring psychiatric or cognitive disorders, and or unstable significant medical conditions

200

The GeneSight arm experienced a _____% relative improvement in response rates at week 8 compared to TAU. Was this statistically significant?

30% ; yes

200

What are pharmacodynamic genes?

what the drugs do to the body


200

What are the secondary outcomes (2)?

Response and Remission rates

300

What was the average number of med failures across the study population?

3.5

300

The GeneSight Psychotropic effect on response and remission rates continued to grow after unblinding and up to _____months.

6 months (durability)

300

The GeneSight arm experienced a _____% relative improvement in remission rates at week 8 compared to TAU. Was this statistically significant?

50% ; yes

300

What are pharmacokinetic genes?

What the body does with the drug

300

What license plate is Claire currently on?

North Carolina

400

Why is the GUIDED study different than other prior clinical trials?

Psychiatry + Primary Care***

400

What are the three levels of Gene-drug interactions

- no gene drug interaction (green use as directed)
- moderate GDI (yellow use with caution)
- severe GDI (red use with extreme caution)

400

The GeneSight arm experienced an ___% relative improvement in symptoms at week 8 compared to TAU. Was this statistically significant?

11% ; no

400

What is the difference between a genotype and a phenotype

Genotype- A persons collection of genes

Phenotype - an expression of a genotype, the observable trait

400

Name 3 limitations to the GUIDED study

-Mostly Caucasian
-treating clinicians not blinded
-Study did not include patients with mild depression, may not be able to generalize to mild depression patients.



500

Who were the principal investigators of the GUIDED study? And which University are they from?

-Dr. John Greden & Dr. Sagar Parikh
-University of Michigan

500

What does GUIDED stand for

Genomics Used to Improve Depression Decisions

500

What did the congruency data focus on and how many of the population?

Only patients that came in on the red bin medication and moved from yellow/ green. (220/1167)



500

What are the four types of metabolizers

Ultrarapid

Extensive (normal) 

intermediate

poor 

500

When looking at patients who were on a red category medication entering the study, when clinicians switched to green or yellow, category medications patients saw a:
___% improvement in remission rates 

___% improvement in response rates
___% increase in symptom improvement at week 8 vs. those who remained on red.

153% improvement in remission rates
71% improvement in response rates
59% increase in symptom improvement